NCT00264498View on ClinicalTrials.gov

Phase II Iressa & Carbo/Gem in NSCLC

PHASE2CompletedINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

June 30, 2008

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

Gefitinib

oral tablet

DRUG

Gemcitabine

intravenous injection

DRUG

Carboplatin

intravenous injection

Trial Locations (1)

Unknown

Research Site, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY